Touchstone International Medical Science Co Ltd (688013) — Capital Reinvestment Ratio
Touchstone International Medical Science Co Ltd (688013) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥27.05 Million) in capital expenditures (CN¥8.28 Million). Check 688013 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Touchstone International Medical Science Co Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Touchstone International Medical Science Co Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see Touchstone International Medical Science operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Touchstone International Medical Science Co Ltd from 2017 to 2024. See Touchstone International Medical Science free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥53.41 Million | CN¥41.94 Million | ▲ +253.8% |
| 2023 | 0.22x | CN¥82.95 Million | CN¥18.41 Million | ▼ -76.5% |
| 2022 | 0.95x | CN¥50.40 Million | CN¥47.67 Million | ▲ +526.2% |
| 2021 | 0.15x | CN¥60.98 Million | CN¥9.21 Million | ▼ -12.9% |
| 2020 | 0.17x | CN¥42.08 Million | CN¥7.29 Million | ▼ -35.9% |
| 2019 | 0.27x | CN¥34.82 Million | CN¥9.41 Million | ▼ -55.2% |
| 2018 | 0.60x | CN¥34.44 Million | CN¥20.78 Million | ▼ -68.7% |
| 2017 | 1.93x | CN¥7.88 Million | CN¥15.21 Million | — |